Generic placeholder image

Mini-Reviews in Medicinal Chemistry


ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Targeting microRNAs in Pathological Hypertrophy and Cardiac Failure

Author(s): Dongchao Lv, Jingqi Liu, Cuimei Zhao, Qi Sun, Qiulian Zhou, Jiahong Xu and Junjie Xiao

Volume 15, Issue 6, 2015

Page: [475 - 478] Pages: 4

DOI: 10.2174/1389557515666150324124751

Price: $65


MicroRNAs (miRNAs) are a novel class of endogenous, short, non-coding, posttranscriptional RNAs, which play important roles in regulating lots of important biological functions. Evidences show that altered expression of miRNAs are involved in pathological hypertrophy and cardiac failure, making it possible to target miRNAs as a novel therapy. In this review, we focus on very recent progresses in the regulation of miRNAs in pathological hypertrophy and cardiac failure. In addition, we also discuss the potential of using miRNAs as a new therapy for pathological hypertrophy and cardiac failure.

Keywords: Cardiac failure, microRNA, pathological hypertrophy, therapy.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy